1. Economic Studies in Motor Neurone Disease: A Systematic Methodological Review

   • Alan Moore
   • Carolyn A. Young
   • Dyfrig A. Hughes

   Systematic Review 14 December 2016 Pages: 397 - 413

   

2. Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

   • Benjamin Kearns
   • Abdullah Pandor
   • M. Satish Kumar

   Review Article 22 October 2016 Pages: 415 - 424

3. Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma

   • Kelly Fust
   • Xiaoyan Li
   • Gary H. Lyman

   Original Research Article Open access 07 December 2016 Pages: 425 - 438

   

4. Is Dimension Order Important when Valuing Health States Using Discrete Choice Experiments Including Duration?

   • Brendan Mulhern
   • Richard Norman
   • Rosalie Viney

   Original Research Article 21 November 2016 Pages: 439 - 451

   

5. Mapping CHU9D Utility Scores from the PedsQL^TM 4.0 SF-15

   • Christine Mpundu-Kaambwa
   • Gang Chen
   • Julie Ratcliffe

   Original Research Article 07 December 2016 Pages: 453 - 467

   

6. Measuring Care-Related Quality of Life of Caregivers for Use in Economic Evaluations: CarerQol Tariffs for Australia, Germany, Sweden, UK, and US

   • Renske J. Hoefman
   • Job van Exel
   • Werner B. F. Brouwer

   Original Research Article Open access 31 December 2016 Pages: 469 - 478

   

7. A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK

   • C. Rinciog
   • M. Watkins
   • A. Diamantopoulos

   Original Research Article Open access 31 December 2016 Pages: 479 - 491